BOVILIS® CORONAVIRUS
Bovine Coronavirus Vaccine
Product Description
Banamine brand of flunixin meglumine is the pioneer injectable nonsteroidal anti-inflammatory drug approved for cattle and horses in the United States.
BOVILIS Coronavirus is recommended for use in healthy cattle against enteric disease caused by bovine coronavirus. Efficacy was demonstrated in calves 3 days of age and older.
Indications
This product has been shown effective for the vaccination of healthy cattle 3 days of age or older against enteric disease caused by bovine coronavirus.
Dosage
2mL administered intranasally to healthy cattle 3 days of age or older.
Diseases
Supplied
1 x 20 mL (10 doses)
25 X 1 mL (25 singles doses)
1 x 100 mL (50 doses)
Safety
Shown safe in cattle 1 day of age and older. This product has not been tested in pregnant animals.
Preservatives
Contains Penicillin and Streptomycin as preservatives.
Caution
Store at 2°-8°C (35°- 46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products, except as specified on this label. Inactivate unused contents before disposal. Do not use chemical disinfectants to sterilize syringes or needles. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant animals. If allergic reaction occurs, treat with epinephrine. In case of human exposure, contact a physician.
FOR INTRANASAL USE ONLY.
FOR ANIMAL USE ONLY
Resources
Contact
U.S. only: Merck Animal Health livestocktechsrvc@merck-animal-health.com or call 1-800-211-3573
For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov
For additional information, please see the product label.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global